Erucin
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Names | |
---|---|
IUPAC name
1-Isothiocyanato-4-methylsulfanylbutane
| |
Other names
4-Methylthiobutyl isothiocyanate
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.158.918 |
EC Number |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H11NS2 | |
Molar mass | 161.28 g·mol−1 |
Hazards | |
GHS labelling:[1] | |
Danger | |
H314 | |
P260, P264, P264+P265, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P363, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Erucin (4-methylthiobutyl isothiocyanate) is a dietary isothiocyanate present in cruciferous vegetables that is considered a potential cancer chemopreventive nutraceutical.[medical citation needed]
Characteristics
[edit]Erucin is produced by the enzymatic hydrolysis of the glucosinolate glucoerucin present in Eruca sativa Mill. seeds (Brassicaceae or Cruciferae). Erucin has structural analogies with sulforaphane (SFN), an isothiocyanate derived from glucoraphanin, a glucosinolate present in some edible crucifers, and known in the literature for its chemopreventive properties. Different isothiocyanates exert anticancer properties on many tumor types (liver, breast, bladder, lung, and pancreatic), and in particular, SFN is employed in a pilot randomized controlled clinical trial in advanced pancreatic cancer.[2]
References
[edit]- ^ "Erucin". pubchem.ncbi.nlm.nih.gov. Retrieved 28 March 2022.
- ^ Martelli, Alma (2019). "Anticancer Activities of Erucin a H2S-Donor Isothiocyanate From Eruca Sativa Mill.: Is H2S the Real Player?". Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders. 327–328. doi:10.1016/B978-0-12-821038-3.00023-9. S2CID 243057730.